Infections and Biologic Therapy in Rheumatoid Arthritis
- 1 November 2012
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 38 (4), 727-745
- https://doi.org/10.1016/j.rdc.2012.08.019
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?Annals Of The Rheumatic Diseases, 2011
- The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control studyAnnals Of The Rheumatic Diseases, 2011
- Initiation of rheumatoid arthritis treatments and the risk of serious infectionsRheumatology, 2009
- Anti–tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritisArthritis & Rheumatism, 2007
- Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonistsArthritis & Rheumatism, 2007
- Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritisAnnals Of The Rheumatic Diseases, 2007
- Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: Associations with prednisone, disease‐modifying antirheumatic drugs, and anti–tumor necrosis factor therapyArthritis & Rheumatism, 2006
- T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infectionTrends in Molecular Medicine, 2004
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002
- Perturbation of the T cell repertoire in rheumatoid arthritisProceedings of the National Academy of Sciences, 1998